Rosigon 4mg Tablet
Marketer
Invision Medi Sciences Pvt Ltd
Salt Composition
Rosiglitazone (4mg)
Overview Rosigon 4mg Tablet
Glicace 4mg tablets are prescribed for adult patients with type 2 diabetes. This medication assists in regulating blood glucose, thereby mitigating the risk of severe diabetic complications such as vision impairment and renal failure. Glicace 4mg tablets can be administered independently or in conjunction with other medications, with or without food. Consistent daily dosing at the same time maximizes effectiveness. Your physician will determine the appropriate dosage, which may be adjusted based on treatment response. Continued use is crucial, even with controlled blood sugar or feeling well; abrupt cessation can elevate blood glucose, potentially leading to kidney disease, blindness, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan including dietary adjustments, physical activity, and weight management as recommended by your doctor. Lifestyle modifications are essential for diabetes control. Common side effects include visual disturbances, paresthesia, and bone fractures. Report persistent or bothersome side effects to your doctor. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or significant hepatic or renal impairment. Prior to commencing treatment, inform your doctor about any history of cardiovascular disease, thyroid disorders, or endocrine conditions, as this medication may not be suitable. Pregnant or lactating individuals should consult their physician before initiating treatment. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Rosigon 4mg Tablet
Managing type 2 diabetes
Major Benefits of Rosigon 4mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 4mg Rosigon tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, however, consistent daily timing is recommended.
Common Side effects of Rosigon 4mg Tablet:
- Blurred vision
- Numbness
- Bone fracture
- Respiratory tract infection
How to use Rosigon 4mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 4mg Rosigon tablet whole; do not crush, chew, or break it. While you can take it with or without food, consistency is key—choose a regular time each day.
How Rosigon 4mg Tablet works:
Glimepiride 4mg tablets are used to manage diabetes. Their mechanism of action involves enhancing the body's responsiveness to insulin, thereby regulating blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rosigon 4mg Tablet with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Rosigon 4mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against the risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Rosigon 4mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Rosigon 4mg tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney impairment may safely take Rosigon 4mg tablets without requiring a dosage modification.
LiverCAUTION
Patients with liver impairment should exercise caution when using Rosigon 4mg tablets; dosage modification may be necessary. Physician consultation is advised. Report any jaundice symptoms to your doctor during treatment.
What if you forget to take Rosigon 4mg Tablet :
Omit any missed Rosigon 4mg Tablet dose and resume your regular medication schedule. Avoid taking a double dose.
Facts to Know About Rosigon 4mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Thiazolidinedione-based compound |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | PPARγ agonist (thiazolidinedione) |
3,018 People bought this recently